Genomic Analysis of Pediatric Bone Tumors
To determine whether gene expression analysis of primary tumor samples before and after chemotherapy are predictive of long-term survival in pediatric patients with bone sarcomas (Ewings sarcoma (ES) and Osteosarcoma(OS)).
Stanford is currently accepting patients for this trial.
Inclusion Criteria:All patients with bone x-rays suggestive of a malignant bone tumor
Exclusion Criteria:Patients with a known diagnosis of cancer.
Ages Eligible for Study
N/A - 18 Years
Genders Eligible for Study